Elevian Company
Elevian develops medicines that restore youthful regenerative capacity, with the potential to treat and prevent many age-related diseases.
Investors
Headquarters:
Allston, Massachusetts, United States
Number Of Exists:
Seed
Total Funding:
24333889
Founded Date:
2017
Employee Number:
1-10
Last Funding Type:
Seed
Investor Type:
Company
Investors Number:
9
Last Funding Date:
2020
Technology:
Regenerative Medicine
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Industry:
Biopharma, Biotechnology